High Vista Strategies LLC Neoleukin Therapeutics, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$9.23 - $13.12 $657,499 - $934,603	-71,235 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.26 - $15.78 $16,980 - $23,796	1,508 Added 2.16%	71,235 $877,000
Q4 2020 Feb 16, 2021	BUY	$10.17 - $14.56 $310,113 - $443,978	30,493 Added 77.72%	69,727 $983,000
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $103,401 - $181,700	10,682 Added 37.41%	39,234 $471,000
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $284,092 - $486,811	28,552 New	28,552 $474,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.